Attenuation of the unfolded protein response and endoplasmic reticulum stress after mechanical unloading in dilated cardiomyopathy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 309, Issue 3, 2015, Pages H459-H470

  Castillero, Estibaliz ^a   Akashi, Hirokazu ^a   Pendrak, Klara ^b   Yerebakan, Halit ^a   Najjar, Marc ^a   Wang, Catherine ^a   Naka, Yoshifumi ^a   Mancini, Donna ^a   Sweeney, H Lee ^b   D’Armiento, Jeanine ^a   Ali, Ziad A ^a   Schulze, P Christian ^a   George, Isaac ^a  

^a New York Presbyterian Hospital College of Physicians and Surgeons of Columbia University ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Endoplasmic reticulum stress; Unfolded protein response; Ventricular assist device

Indexed keywords

BINDING IMMUNOGLOBULIN PROTEIN; BIOLOGICAL MARKER; CALCIMYCIN; CALCIUM; CALRETICULIN; CALSEQUESTRIN; CCAAT ENHANCER BINDING PROTEIN; INITIATION FACTOR 2ALPHA; PROTEIN SERCA2A; RYANODINE RECEPTOR; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN; THAPSIGARGIN; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; DNA BINDING PROTEIN; PROTEIN KINASE R; REGULATORY FACTOR X TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ADULT; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DNA DAMAGE; ENDOPLASMIC RETICULUM STRESS; EXPLANT; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HUMAN TISSUE; LEFT VENTRICULAR ASSIST DEVICE; MALE; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; REGULATORY MECHANISM; UNFOLDED PROTEIN RESPONSE; CARDIOMYOPATHY, DILATED; CASE CONTROL STUDY; CELL LINE; GENETICS; HEART ASSIST DEVICE; HEART VENTRICLE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

APOPTOSIS; CALRETICULIN; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CELL LINE; DNA-BINDING PROTEINS; EIF-2 KINASE; ENDOPLASMIC RETICULUM STRESS; FEMALE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRANSCRIPTION FACTORS; UNFOLDED PROTEIN RESPONSE;

EID: 84938634730     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00056.2015     Document Type: Article

References (40)

1. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 72: 463–469, 1993.
2. Ather S, Respress JL, Li N, Wehrens XH. Alterations in ryanodine receptors and related proteins in heart failure. Biochim Biophys Acta 1832: 2425–2431, 2013.
3. Baba HA, Wohlschlaeger J. Morphological and molecular changes of the myocardium after left ventricular mechanical support. Curr Cardiol Rev 4: 157–169, 2008.
4. Bachar E, Ariav Y, Ketzinel-Gilad M, Cerasi E, Kaiser N, Leibowitz G. Glucose amplifies fatty acid-induced endoplasmic reticulum stress in pancreatic beta-cells via activation of mTORC1. PLoS One 4: e4954, 2009.
5. Birks EJ. Molecular changes after left ventricular assist device support for heart failure. Circ Res 113: 777–791, 2013.
6. Davidson MM, Nesti C, Valenzuela L, Walker WF, Hernandez E, Protas L, Hirano M, Isaac ND. Novel cell lines derived from adult human ventricular cardiomyocytes. J Mol Cell Cardiol 39: 133–147, 2005.
7. Dipla K, Mattiello JA, Jeevanandam V, Houser SR, Margulies KB. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 97: 2316–2322, 1998.
8. Dixon IM, Hata T, Dhalla NS. Sarcolemmal calcium transport in congestive heart failure due to myocardial infarction in rats. Am J Physiol Cell Physiol 262: C1387–C1394, 1992.
9. Drakos SG, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Terrovitis JV, Nanas JN, Li DY. Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation 126: 230–241, 2012.
10. 2+ exchanger in failing human myocardium. Circulation 94: 992–1002, 1996.
11. Frazier OH, Benedict CR, Radovancevic B, Bick RJ, Capek P, Springer WE, Macris MP, Delgado R, Buja LM. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 62: 675–681, 1996.
12. George I, Sabbah HN, Xu K, Wang N, Wang J. β-Adrenergic receptor blockade reduces endoplasmic reticulum stress and normalizes calcium handling in a coronary embolization model of heart failure in canines. Cardiovasc Res 91: 447–455, 2011.
13. Glembotski CC. The role of the unfolded protein response in the heart. J Mol Cell Cardiol 44: 453–459, 2008.
14. 2+- exchanger protein levels and diastolic function of failing human myocardium. Circulation 99: 641–648, 1999.
15. Heerdt PM, Holmes JW, Cai B, Barbone A, Madigan JD, Reiken S, Lee DL, Oz MC, Marks AR, Burkhoff D. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 102: 2713–2719, 2000.
16. Hirota M, Kitagaki M, Itagaki H, Aiba S. Quantitative measurement of spliced XBP1 mRNA as an indicator of endoplasmic reticulum stress. J Toxicol Sci 31: 149–156, 2006.
17. 2+ pump activity in response to endoplasmic reticulum stress in PC12 cells. BMC Biochem 2: 4, 2001.
18. 2+ exchange in the infarcted heart. Implications for excitation-contraction coupling. Circ Res 81: 1083– 1093, 1997.
19. Liu CL, Li X, Hu GL, Li RJ, He YY, Zhong W, Li S, He KL, Wang LL. Salubrinal protects against tunicamycin and hypoxia induced cardiomyocyte apoptosis via the PERK-eIF2α signaling pathway. J Geriatr Cardiol 9: 258–268, 2012.
20. Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal 9: 2277–2293, 2007.
21. Mancini DM, Beniaminovitz A, Levin H, Catanese K, Flannery M, DiTullio M, Savin S, Cordisco ME, Rose E, Oz M. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 98: 2383–2389, 1998.
22. Margariti A, Li H, Chen T, Martin D, Vizcay-Barrena G, Alam S, Karamariti E, Xiao Q, Zampetaki A, Zhang Z, Wang W, Jiang Z, Gao C, Ma B, Chen YG, Cockerill G, Hu Y, Xu Q, Zeng L. XBP1 mRNA splicing triggers an autophagic response in endothelial cells through BECLIN-1 transcriptional activation. J Biol Chem 288: 859–872, 2013.
23. Patterson C, Willis Calcium cycling M. In: Translational Cardiology: Molecular Basis of Cardiac Metabolism, Cardiac Remodeling, Translational Therapies and Imaging Techniques, edited by Springer Science & Business Media. New York, NY. Humana, 2012.
24. Perreault CL, Meuse AJ, Bentivegna LA, Morgan JP. Abnormal intracellular calcium handling in acute and chronic heart failure: role in systolic and diastolic dysfunction. Eur Heart J 11: 8–21, 1990.
25. 2+ exchanger transcription a marker for different stages of myocardial dysfunction? Quantitative polymerase chain reaction of the messenger RNA in endomyocardial biopsies of patients with heart failure. J Am Coll Cardiol 36: 233–241, 2000.
26. 2+ exchange activity in patients with end-stage heart failure. Cardiovasc Res 31: 48–54, 1996.
27. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8: 519–529, 2007.
28. 2+ exchanger protein levels in human heart failure. Circulation 99: 2105–2112, 1997.
29. Sen S, Kundu BK, Wu HC, Hashmi SS, Guthrie P, Locke LW, Roy RJ, Matherne GP, Berr SS, Terwelp M, Scott B, Carranza S, Frazier OH, Glover DK, Dillmann WH, Gambello MJ, Entman ML, Taegtmeyer H. Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart. J Am Heart Assoc 2: e004796, 2013.
30. Sipido KR, Volders PG, Vos MA, Verdonck F. Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy? Cardiovasc Res 53: 782–805, 2002.
31. 2+ exchanger in end-stage human heart failure. Circ Res 75: 443–453, 1994.
32. Tanjore H, Lawson WE, Blackwell TS. Endoplasmic reticulum stress as a pro-fibrotic stimulus. Biochim Biophys Acta 1832: 940–947, 2013.
33. Terracciano CM, Hardy J, Birks EJ, Khaghani A, Banner NR, Yacoub MH. Clinical recovery from end-stage heart failure using leftventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation 108: 2263–2265, 2004.
34. Thuerauf DJ, Marcinko M, Gude N, Rubio M, Sussman MA, Glembotski CC. Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circ Res 99: 275–282, 2006.
35. Wang Q, Jiang H, Fan Y, Huang X, Shen J, Qi H, Li Q, Lu X, Shao J. Phosphorylation of the α-subunit of the eukaryotic initiation factor-2 (eIF2α) alleviates benzo[a]pyrene-7,8-diol-9,10-epoxide induced cell cycle arrest and apoptosis in human cells. Environ Toxicol Pharmacol 31: 18–24, 2011.
36. Wang W, Wehrens XH. Stress synchronizes calcium release and promotes SR calcium leak. J Physiol 588: 391–392, 2010.
37. Wei X, Li T, Hagen B, Zhang P, Sanchez PG, Williams K, Li S, Bianchi G, Son HS, Wu C, DeFilippi C, Xu K, Lederer WJ, Wu ZJ, Griffith BP. Short-term mechanical unloading with left ventricular assist devices after acute myocardial infarction conserves calcium cycling and improves heart function. JACC Cardiovasc Interv 6: 406–415, 2013.
38. Wohlschlaeger J, Schmitz KJ, Schmid C, Schmid KW, Keul P, Takeda A, Weis S, Levkau B, Baba HA. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. Cardiovasc Res 68: 376–386, 2005.
39. 2+ in vascular smooth muscle cells. Am J Physiol Cell Physiol 280: C843–C851, 2001.
40. Zsebo KM, Yaroshinsky A, Rudy JJ, Wagner K, Greenberg B, Jessup M, Hajjar RJ. Long term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality. Circ Res 114: 101–108, 2014.